Dr. Fatimah Nahhas has over 20 years of experience in the field of Genetic Testing. She is a diplomate of the American Board of Medical Genetics and Genomics and a fellow of the American College of Medical Genetics and certified by the New York State and Florida State Departments of Health. In her current role, Dr Nahhas is a laboratory director from the Molecular Genetics team at Labcorp Genetics.
Dr Nahhas graduated from Wayne State University with PhD in Molecular Biology and Genetics. Prior to joining Labcorp, she worked as a technical director at Detroit Medical Center Molecular Diagnostic Laboratory, PhD Section Director at Johns Hopkins All Children's Hospital, Senior Laboratory Director at Sema4 Diagnostics and Laboratory Director at Invitae.
Areas of Support: Molecular Genetics and Genomics
Memberships: ACMG, ABMGG, AMP
Board Certifications: ABMGG Clinical Molecular Genetics, ABMGG Laboratory Genetics and Genomics
Publications:
- Jay AM, Conway RL, Feldman GL, Nahhas F, Spencer L, Wolf B. 2015. Outcomes of individuals with profound and partial biotinidase deficiency ascertained by newborn screening in Michigan over 25 years. Genet Med 17(3):205-209.
- Wakeling E, Nahhas F, Feldman G. 2014. Extra alleles in FMR1 triple-primed PCR: artifact, aneuploidy, or somatic mosaicism? J Mol Diagn 16(6):689-696.
- Li H, Spencer L, Nahhas F, Miller J, Fribley A, Feldman G, Conway R, Wolf B. 2014. Novel mutations causing biotinidase deficiency in individuals identified by newborn screening in Michigan including an unique intronic mutation that alters mRNA expression of the biotinidase gene. Mol Genet Metab 112(3):242-6.
- Nahhas FA, Monroe TJ, Prior TW, Botma PI, Fang J, Snyder PJ, Talbott SL, Feldman GL. 2012. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory. Genet Test Mol Biomarkers 16(3):187-92.
- Nahhas F, Garbern J, Feely S, Feldman G. 2009. An Intergenerational Contraction of a Fully Penetrant Huntington Disease Allele to a Reduced Penetrance Allele: Interpretation of Results and Significance for Risk Assessment and Genetic Counseling. Am J Med Genet A 149A(4):732-736.
- Nahhas F, Dryden SC, Abrams J, Tainsky MA. 2007. Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin. Mol Cell Biochem. 303(1-2):221-30.
- Fridman A, Tang L, Kulaeva O, Ye B, Li Q, Nahhas F, Roberts P, Land S, Abrams J, Tainsky A. 2006. Expression Profiling Identifies Three Pathways Altered in Cellular Immortalization: Interferon, Cell Cycle and Cytoskeleton. J Gerontol A Biol Sci Med Sci 61(9):879-889.
- Chatterjee M, Mohapatra S, Wang X, Nowak J, Nahhas F, Lu K, Witkin S, Fishman D, Munkarah A, Morris R, Levin N, Tromp G, Abrams J, Draghici S, Tainsky M. 2006. Diagnostic Markers of Ovarian Cancer by High-throughput Antigen Cloning and Detection on Arrays. Cancer Res 66(2):1181-1190.
- Dryden, SC, Nahhas FA, Nowak GE, Goustin AS, Tainsky MA. 2003. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol Cell Biol. 23(9):3173-85.
- Virgin JB, Hurley PM, Nahhas FA, Bebchuk KG, Mohamed AN, Sakr WA, Bright RK, Cher ML. 1999. Isochromosome 8q formation is associated with 8p loss of heterozygosity in a prostate cancer cell line. Prostate 41(1):49-57